Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy
Translational Vision Science & Technology · 2023
DOI: 10.1167/tvst.12.2.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2023. Verfasst von Mohamed Ashraf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Retinal Diseases, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA.
- Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
- Ophthalmology Department, Alexandria Faculty of Medicine, Alexandria, Egypt.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Ashraf, M., Sun, J. K., Silva, P. S., & Aiello, L. P. (2023). Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.12.2.7
Vancouver
Ashraf M, Sun JK, Silva PS, Aiello LP. Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy. Translational Vision Science & Technology. 2023. doi:10.1167/tvst.12.2.7
BibTeX
@article{Ashraf2023,
author = {Ashraf, Mohamed and Sun, Jennifer K and Silva, Paolo S and Aiello, Lloyd Paul},
title = {Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy},
journal = {Translational Vision Science & Technology},
year = {2023},
doi = {10.1167/tvst.12.2.7}
}
EUVIMED